ArticlePatient preference and adherence2026
Inhaled Medication Adherence Trajectory and Its Associated Factors in Patients with Chronic Obstructive Pulmonary Disease: A Group-Based Trajectory Modeling.
Article in Patient preference and adherence, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Objective: This study aims to identify the heterogeneous trajectories of inhaled medication adherence in COPD patients while examining their associated factors and exploring the longitudinal correlation between variables, so as to provide the basis for precise intervention. Methods: Adopting convenience sampling, chronic obstructive pulmonary disease (COPD) patients hospitalized at The First Affiliated Hospital of Guangzhou Medical University between December 2023 and September 2024 were recruited. General information, Test of the Adherence to Inhalers (TAI; scores of 50 indicate high adherence, 46-49 moderate adherence, and ≤45 low adherence), Chronic Obstructive Pulmonary Disease Knowledge Questionnaire (COPD-Q), Beliefs about Medicines Questionnaire-Specific (BMQ-Specific), Hospital Anxiety and Depression Scale (HADS), and Perceived Social Support Scale (PSSS) were assessed at hospitalization (T0) and 1 month (T1), 3 months (T2), and 6 months (T3) after discharge. The Group-Based Trajectory Model was employed to identify inhaled medication adherence trajectories. Associated factors of trajectories were determined using multinomial logistic regression, and the longitudinal association between variables was explored by the Group-Based Dual Trajectory Model. Results: A total of 207 patients with COPD completed follow-up. The number and proportion of COPD patients with "medium-low adherence" showed a significant decrease from T0 to T1, followed by an increase from T1 to T3. Trajectories of inhaled medication adherence in COPD patients can be categorised into four classes: "high adherence-persisting group" (50.4%), "medium-low adherence-persisting group" (18.4%), "low adherence rising-persisting group" (15.0%), and "low adherence rising- declining group" (16.3%). Duration of inhalation device use, health literacy, beliefs about medicines, anxiety, and perceived social support were associated factors of trajectories of inhaled medication adherence ( Conclusion: Nearly one-third of COPD patients exhibited poor inhaled medications adherence after discharge, with one month post-discharge serving as a critical turning point. Healthcare providers should prioritize monitoring adherence changes during this period. Four heterogeneous adherence trajectories were identified. Factors influencing each trajectory included: duration of inhaler device use ≤2 years, low level of health literacy, low level of beliefs about medicines, high level of anxiety, and low level of perceived social support. Early screening of these populations and implementation of targeted strategies are essential to enhance precision management.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.